© 2020 – 2024 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
Image default
News

Hundreds of thousands face being denied revolutionary new dementia drugs in England

Exclusive: Treatments near approval but lack of diagnostic capacity means NHS is unprepared for rollout, says report

  • What are the symptoms of dementia and how do you get a diagnosis?

Hundreds of thousands of dementia patients in England face being denied access to revolutionary new drugs because the diagnostic capacity of the NHS lags behind every other G7 country, according to a damning report.

After decades of research to find a cure for the condition projected to affect 153 million people worldwide by 2050, scientists have successfully developed the first treatments to tackle the underlying causes rather than only relieve the symptoms. Two new drugs could get the green light for use on the NHS within weeks.

Continue reading…

Related posts

UK likely to miss Paris climate targets by wide margin, analysis shows

AEA3

Ministers expected to sign off plan B Covid rules for England

AEA3

Russia-Ukraine war live: Putin threatens to strengthen nuclear forces; Nato chief sees ‘signs’ China may provide support to Russia

AEA3